Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5493316

CC(S)S.O=C(O)C(F)(F)F

nearest known ligand 0.37

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RNPEP Q9H4A4 1/20 0.36
ALDH1A1 P00352 5/20 0.35
TDP1 Q9NUW8 3/20 0.35
MAPT P10636 3/20 0.35
HPGD P15428 2/20 0.35
HSD17B10 Q99714 2/20 0.35
LMNA P02545 2/20 0.35
ABCB11 O95342 1/20 0.35
F2 P00734 1/20 0.35
TP53 P04637 1/20 0.35
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
ALOX15 P16050 1/20 0.35
KMT2A Q03164 1/20 0.35
DUSP3 P51452 1/20 0.35
PTPN5 P54829 1/20 0.35
PTPN11 Q06124 1/20 0.35
CYP2C9 P11712 1/20 0.35
HIF1A Q16665 1/20 0.35
TSHR P16473 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL449641 0.97 RNPEP (0.35) RNPEPALDH1A1TDP1MAPTHPGD
Trifluoroacetic Acid SCHEMBL16394297 0.85
Trifluoroacetic Acid SCHEMBL3140803 0.84 TP53 (0.44) ALDH1A1LMNATP53TSHRL3MBTL1
Trifluoroacetic Acid SCHEMBL27714775 0.84 TP53 (0.44) ALDH1A1LMNATP53TSHRL3MBTL1
Trifluoroacetic Acid SCHEMBL4544068 0.83
Trifluoroacetic Acid SCHEMBL7793452 0.81 TP53 (0.42) ALDH1A1LMNATP53TSHRL3MBTL1
Trifluoroacetic Acid SCHEMBL3055318 0.81 ALDH1A1 (0.38) ALDH1A1LMNATP53TSHRL3MBTL1
Trifluoroacetic Acid SCHEMBL20854191 0.81 ALDH1A1 (0.35) ALDH1A1HSD17B10TP53TSHRL3MBTL1
Trifluoroacetic Acid SCHEMBL7209644 0.81 ALDH1A1 (0.35) ALDH1A1TP53TSHRL3MBTL1THRB
Trifluoroacetic Acid SCHEMBL1035693 0.81 TP53 (0.42) ALDH1A1LMNATP53TSHRL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7250395-B2 Especially fused to dihydrofolate reductase, used for treating diseases marked by increased angiogenesis BEIJING INSTITUTE FOR CANCER RESEARCH (CN) 2007-07-31 US disclosed
US-20050154187-A1 Especially fused to dihydrofolate reductase, used for treating diseases marked by increased angiogenesis; also polynucleotides encoding the polypeptide and use of the polynucleotides in gene therapy. BEIJING INSTITUTE FOR CANCER RESEARCH (CN) 2005-07-14 US disclosed
EP-0277561-B1 NEW ARGININE DERIVATIVE, PROCESS FOR THE PREPARATION THEREOF AND ITS USE IN PEPTIDE SYNTHESIS ENIRICERCHE S.p.A. (IT) 1992-04-15 EP disclosed
EP-0277561-A1 New arginine derivative, process for the preparation thereof and its use in peptide synthesis ENIRICERCHE S.p.A. (IT) 1988-08-10 EP disclosed